Skip to main content

Table 1 Baseline characteristics of patients, stratified by presence of mechanical valves

From: Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks

 

All patients

Mechanical valve

No mechanical valve

N = 411

N = 257

N = 154

Age - yr ± S.D.

66.67

± 11.92

65.56

± 10.04

65.85

± 14.56

Age > 65 - no. (%)

208

50.6%

129

50.2%

79

51.3%

Male sex - no. (%)

178

43.3%

90

35.0%

88

57.1%

Medical history - no. (%)

 Rheumatic heart disease

251

61.1%

224

87.2%

27

17.5%

 Mitral stenosis (native valve)

13

3.2%

0

0.0%

13

8.4%

 Tricuspid regurgitation (at least moderate)

156/277

56.3%

111/186

59.7%

45/91

49.5%

 Prior transient ischemic attack

21

5.1%

16

6.2%

5

3.3%

 Prior ischemic stroke

54

13.1%

32

12.5%

22

14.3%

 Prior non-CNS embolic event

3

0.7%

1

0.4%

2

1.3%

 Hypertension

159

38.7%

89

34.6%

70

45.5%

 Diabetes mellitus

100

24.3%

58

22.6%

42

27.3%

 Chronic kidney disease (eGFR< 30 ml/m2)

68

16.5%

35

13.6%

33

21.4%

 Cardiomyopathy

112

27.3%

37

14.4%

75

48.7%

 Coronary artery disease

61

14.8%

19

7.4%

42

27.3%

 Percutaneous coronary intervention

30

7.3%

6

2.2%

24

15.6%

 Coronary-artery bypass surgery

15

3.7%

7

2.7%

8

5.2%

 Left ventricular ejection fraction < 50%

147

35.8%

74

28.8%

73

47.4%

 Left ventricular ejection fraction - percentage point ± S.D

50.75

± 17.66

53.74

± 15.92

45.75

± 19.27

  1. Abbreviation: S.D. standard deviation